- ROUNDTABLE: Improving patient outcomes, controlling costs with OTCs
- Americans more likely than others to prefer generics, study finds
- Novartis names new head of sales U.S.
- NACDS, NCPA, GPhA express support for Drug Quality and Security Act
- Generic drug prices spike, but PBMs' reimbursement rates don't keep up, NCPA study finds
PARSIPPANY, N.J. — Generic drug maker Watson Pharmaceuticals has launched its version of a contraceptive made by Bayer HealthCare Pharmaceuticals, Watson said.
The company announced the launch of Vestura (drospirenone and ethinyl estradiol), a generic version of Bayer's Yaz.
Yaz and its generic versions had sales of about $510 million during the 12-month period ended in November, according to IMS.